Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
100,740,741
-
Number of holders
-
148
-
Total 13F shares, excl. options
-
37,906,037
-
Shares change
-
+8,212,629
-
Total reported value, excl. options
-
$1,224,325,864
-
Value change
-
+$269,590,730
-
Put/Call ratio
-
4.46%
-
Number of buys
-
88
-
Number of sells
-
-49
-
Price
-
$32.3
Significant Holders of FIBROGEN INC - Common Stock, $0.01 par value (FGEN) as of Q2 2017
168 filings reported holding FGEN - FIBROGEN INC - Common Stock, $0.01 par value as of Q2 2017.
FIBROGEN INC - Common Stock, $0.01 par value (FGEN) has 148 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 37,906,037 shares
of 100,740,741 outstanding shares and own 37.63% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (5,808,439 shares), BlackRock Inc. (5,001,406 shares), FMR LLC (3,335,997 shares), STATE STREET CORP (1,763,387 shares), Hillhouse Capital Management, Ltd. (1,750,000 shares), EcoR1 Capital, LLC (1,585,457 shares), JANUS HENDERSON GROUP PLC (1,412,799 shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (1,120,000 shares), FARALLON CAPITAL MANAGEMENT LLC (1,072,000 shares), and JPMORGAN CHASE & CO (1,070,781 shares).
This table shows the top 148 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.